Moderna Covid-19 Vaccine | The Business Standard
Skip to main content
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
The Business Standard

Monday
January 30, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
MONDAY, JANUARY 30, 2023

Moderna Covid-19 Vaccine

File Photo: A woman holds a small bottle labeled with a "Vaccine Covid-19" sticker and a medical syringe in this illustration taken April 10, 2020. Reuters/Dado Ruvic/Illustration
Coronavirus chronicle

Variant-adapted Covid vaccine wins first approval in Britain

Coronavirus: On 16 November, 2020, US biotech company Moderna announced a vaccine against Covid-19 that is 94.5% effective. Montreal, 16 November, 2020/ Reuters
Global Economy

Covid vaccine maker Moderna flags Japan ambition with sumo sponsorship

Vials with a sticker reading, "Covid-19 / Coronavirus vaccine / Injection only" and a medical syringe are seen in front of a displayed Moderna logo in this illustration taken October 31, 2020. Photo :Reuters
Coronavirus chronicle

Moderna seeks FDA authorisation for second Covid booster for all adults

Vials with a sticker reading, "Covid-19 / Coronavirus vaccine / Injection only" and a medical syringe are seen in front of a displayed Moderna logo in this illustration taken October 31, 2020. Photo :Reuters
Covid-19 in Bangladesh

Moderna jabs to be given as boosters instead of Pfizer

Moderna has recently signed vaccine orders for 2022 worth $17 billion — which would make it one of the best-selling drugs in the world. Photo: Reuters
Coronavirus chronicle

Moderna could be ready to develop omicron booster in weeks: CEO

REUTERS/Dado Ruvic/Illustration
Coronavirus chronicle

Moderna Covid-19 vaccine patent dispute headed to court, US NIH head says

Moderna seeks EU authorisation for Covid-19 vaccine in young kids
Coronavirus chronicle

Moderna seeks EU authorisation for Covid-19 vaccine in young kids

A healthcare worker holds a vial of the Moderna Covid-19 vaccine at a pop-up vaccination site operated by SOMOS Community Care during the coronavirus disease (Covid-19) pandemic in Manhattan in New York City, New York, US, January 29, 2021. Photo :Reuters
Coronavirus chronicle

French health authority advises against Moderna Covid-19 vaccine for under 30s

Coronavirus: On 16 November, 2020, US biotech company Moderna announced a vaccine against Covid-19 that is 94.5% effective. Montreal, 16 November, 2020/ Reuters
Coronavirus chronicle

Moderna cuts 2021 sales forecast for Covid-19 vaccine; shares tumble

The exterior of EMA, European Medicines Agency is seen in Amsterdam, Netherlands December 18, 2020. Photo :Reuters
Coronavirus chronicle

Europe drug regulator backs use of Moderna's Covid-19 booster vaccine

FILE PHOTO: A healthcare worker holds a vial of the Moderna COVID-19 vaccine at a pop-up vaccination site operated by SOMOS Community Care during the coronavirus disease (COVID-19) pandemic in Manhattan in New York City, New York, U.S., January 29, 2021. REUTERS/Mike Segar/File Photo
Coronavirus chronicle

US FDA clears Moderna, J&J Covid-19 boosters, backs use of different vaccine for boost

Syringes filled with a dose of the Moderna COVID-19 vaccine sit on a table during an employee vaccination at the Sarasota Memorial Hospital in Sarasota, Florida, U.S., September 24, 2021. REUTERS/Shannon Stapleton
Coronavirus chronicle

Moderna pushes for Covid-19 vaccine boosters in older adults, high-risk individuals

Moderna to deliver another 1 bln vaccine doses to low-income countries next year
Coronavirus chronicle

Moderna to deliver another 1 bln vaccine doses to low-income countries next year

  • Show More
EMAIL US
[email protected]
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]